chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vision improved a week after receiving the second dose; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955), via an unspecified route of administration in the left arm on 15Mar2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. Medical history included EpiLasik surgery at the age of 23 to treat short sightedness, migraine headaches and PTSD. In Oct2020, the patient developed a blurred vision all of a sudden, along with headache and confusions. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any concomitant medications with two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6201), via an unspecified route of administration in the left arm on 22Feb2021 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient thought her pre-existing health condition might have got worse and she was surprised when her vision improved a week on 22May2021 after receiving the second dose. She was joking that the vaccine could cure eye problems until she read a recent article which stated about 30% of the long hauling COVID patients who did not suffer the disease's severity developed blurred vision. She wondered whether Pfizer had ever followed up with their study participants (or actual vaccination outcomes) to know if they experienced any vision problems. She thought of reporting her experience anyway. The adverse events did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event unexpected therapeutic benefit. The clinical outcome of the event unexpected therapeutic benefit was unknown.   No follow-up attempts are possible. No further information is expected.
Headache within 5 minutes.  Within 3 minutes stomach pain, stiffness/tightness, stiffness/tightness in extremities legs, calves, arms, stomach, neck, all over tightness/stiffness.  Dizziness, slight blurry vision, fuzzy feeling.  All these symptoms persisted for 1 full week, with slight relief after 1 week, but continuing into second week.
1. Nurse made error giving a third Men B. GSK MenB is a series of 2 vaccines. 2.  Patient presented  to clinic the next morning with facial numbness on left, dx Bell's palsy.  It can not be ruled out that it was due to vaccine being given in error.
Can't eat anything; Anxious; dizziness; Nauseous; fever; diarrhea; Achiness all over body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and PAIN (Achiness all over body) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever). On 17-Jan-2021, the patient experienced EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous). On 15-Jan-2021, DIARRHOEA (diarrhea), PAIN (Achiness all over body) and PYREXIA (fever) had resolved. At the time of the report, EATING DISORDER (Can't eat anything), ANXIETY (Anxious), DIZZINESS (dizziness) and NAUSEA (Nauseous) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Low grade fever and flushing to face and upper neck beginning around 5:30pm on Tuesday 20th of April.  2 Ibuprofen taken orally.  Temperature was normal when checked 45 minutes after taking ibuprofen.  Pain, tenderness, and swelling of lymph node in Right armpit noticed approximately an hour after low grade fever.  Lymph node became warm, quite swollen and painful with what seemed to be excess fluid around it.  2 Ibuprofen were taken at 11:30pm, no reducing in symptoms detected.  Lymph node was still very swollen and painful the next morning so a warm compress was applied which provided a small amount of comfort but did not reduce swelling.  By 11am on the 21st lymph node was so painful that I took 500mg Naproxen.  Swelling of the lymph node reduced approximately an hour to hour and a half after taking Naproxen, but swelling was not entirely eliminated.  Swelling of lymph node continues as of today, Thursday.  Injection site pain, feeling 'bruised' as well as red and hard approx. size of nickel.
Patient sustained a vasovagal syncope event about 3 to 4 minutes subsequent to vaccine administration. Struck back of head on chair with fall to ground. Evaluated by medical staff and referred to medical center via ER non-emergent transport. Subsequent to ER staff evaluation for syncope and head injury, she was treated and released from the ER without need for further work-up or imaging.
COVID-19 breakthrough. I started having symptoms around the 27th of March 2022. I had fatigue, chills, mild fever (highest 101 degrees). I took an at home COVID-19 test that came back negative however my symptoms continued to worsen. A couple of days later it got to the point that I wasn't able to work. I went to the doctor and I was tested for the flu and COVID-19 and the COVID-19 test came back positive. I was told to rest and to not return to work until that following week. I took acetaminophen and ibuprofen which seemed to help with the fever. Majority of my symptoms were gone by that next week but I was experiencing prolonged fatigue and some brain fog I am still experiencing some of that today.
Within 3 hours -> fatigue/pain/crying/lack focus on parents/fussy for 1 week/high pitched scream.
headache, sinus pressure, post nasal drip, clogged ears, ringing ears, neck pain - noticed these symptoms after the acute side effects (headache, fatigue, chills) of vaccine wore off and still experiencing them 6 days later
Pain, soreness, swelling left arm - redness - left upper arm extended to forearm. Persisted up to 5 - 7 days. No symptoms at present 10-18-07 onset within 1-2 hours after the vaccines.
Facial Rash-itch and swelling around 5-6pm after being given the vaccine at 2:02pm. Patient reported to the nurse on 09/30/2021 and stated there was no trouble breathing and that Benadryl was helping with the rash and swelling.  Patient has allergy to thimersol so a prefilled syringe was needed. High dose was picked up and administered instead of appropriate dose for patient age.
Pt stated a couple of hour after receiving the shot she experienced pain. Each day it has increased. Now at 10 days. She fells it under her arm - travelling up her neck. Per pt it has increased more every day. Daughter had one same day and was fine.
pt recv vax 230PM & parent reported pt had sz, foaming in mouth, eyes rolled upward, arm & head thrusting up & sideways lasting for a min about 5:30PM;pt taken to hosp;exam OK following day;
small light pink ball of discharge urinating, menstral cramp off and on next 2 days  12/15 vaginal discharge-16 yrars ago last menstral cycle
91 y.o. female with PMH of HTN, HFpEF, CKD III who presents from cardiology clinic to local ER after large pericardial effusion was incidentally found along with moderate L pleural effusion. She had a pacemaker placed after she had 18 seconds of ventricular standstill that resulted in syncope one month ago. 2 weeks ago she presented to local ER with atypical chest pain. She described the pain as sharp that worsened with inspiration and position. It was worse when lying flat. She had negative troponins and EKG and was sent home. Since her discharge she had continued to have significant chest pain requiring her to take hydrocodone, Tylenol, and ibuprofen without much relief. Today she was seen in follow up for her pacemaker. She notes she has become progressively more SOB as she can barely walk without feeling SOB and currently is SOB at rest. She says she cannot take a deep breaths because she will cough incessantly and also because it hurts. She had a viral URI a few weeks ago, she tells me with sinus congestion, and cough. Her COVID-19 test is positive.
Immunizations given 12/27/04. Developed respiratory difficulties with stridor that afternoon. Color good. Was irritable. Admitted to hospital for observation. By evening, he was clear; no respiratory symptoms. Discharged 12/28/04 AM.
Pain, erythema and warmth approx 8x15 cm area of (R) upper arm occurring 1 day after vaccine given. Treated with ice and NSAIDS.
After all vaccines & boosters, contracted Covid 2 weeks ago; After all vaccines & boosters, contracted Covid 2 weeks ago; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in 2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "C-19", start date: Mar2020 (unspecified if ongoing), notes: My first experience with C-19 was March 2020. The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed; Manufacturer Unknown), for COVID-19 immunisation; Covid-19 vaccine (DOSE NUMBER UNKNOWN (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Nov2023, outcome "unknown" and all described as "After all vaccines & boosters, contracted Covid 2 weeks ago". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: C-19 vaccines, Paxlovid and the continuing work your company did in Research and development. After all vaccines & boosters, patient contracted Covid 2 weeks ago. Patient's first experience with C-19 was Mar2020. Patient had phone consults with a virologist and managed symptoms at home. Patient thought Mar2020 was end. Nov2023, was so different. People didn't get the difference. Patient did.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Right thigh (injection site) warm, swollen, red and very painful to touch. It has been 32 days and her thigh is still red and slightly swollen but no longer painful.
Constriction/ contraction of throat, then eyes and head and then chest. Felt like I was having a heart attack with feeling of great pressure on chest. Last a little over an hour.
Pt had a vasovagal episode shortly after receiving Anthrax and Typhoid vaccines. She was assisted to the ground and was treated immediately. Pt's symptoms included pale skin, weakness, tingling in both hands, dizziness, and syncope. Pt's legs were elevated, vital signs were taken (BP- 102/78, P-68, SPO2-100%), and medical provider arrived at the scene for evaluation. Pt was given water, an orange, crackers, ham, cheese, almonds, and a granola bar as she was on an empty stomach. Pt was in observation for approximately 30 minutes. After patient was cleared by medical director, pt went to lab and had another vasovagal episode with the same symptoms as above, while in the waiting room. Pt was seen by medical director again and was in observation for approximately 45 minutes before she had a third vasovagal episode while in observation. Medical director evaluated patient and ordered bloodwork that is currently pending results (CBC, CMP). Pt took a home pregnancy test while she was in observation with negative results. Pt declines any history of reactions/vasovagal episodes with any vaccines in the past.
Moderna Covid-19 vaccine which has undergone multiple temperature excursions.; Moderna Covid-19 vaccine which has undergone multiple temperature excursions.; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.) and POOR QUALITY PRODUCT ADMINISTERED (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.) in a 61-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 09-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.) and POOR QUALITY PRODUCT ADMINISTERED (Moderna Covid-19 vaccine which has undergone multiple temperature excursions.) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   The Nurse reported no adverse reactions or side effects to the Moderna Covid-19 vaccine. Reporter did not had information available on the patient's first two doses.  Storage condition at the time of the excursion: refrigerated storage. Date vial(s) moved from freezer to refrigerator. 03 Mar 2022. Visual inspection was reported as vials were not visualized. Maximum Temperature was 49 degrees Farenheight and Minimum Temperature is 37.7 degrees Farenheight.  Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.
This spontaneous report was received from a medical assistant via a company representative referring to a 57 year old female patient. There was no information about the patient's pertinent medical history, concurrent conditions, drug reactions or allergies and concomitant medications provided. On 24-MAY-2017, the patient was vaccinated with PNEUMOVAX23 (dose and route were not reported) lot # N010105, expiration date: 15-NOV-2018 for prevention of pneumonia. On an unknown date, the patient experienced arm pain and stiffness in the arm, with difficulty bending the arm and "could not flex". The patient was prescribed a DEPO-MEDROL shot and atenolol by an unspecified provider at the office. The outcome of arm pain and stiffness was unknown. Causality assessment was not reported. A product quality complaint was not involved. Lot # N010105, expiration date: 15-NOV-2018 has been verified to be a valid lot number for pneumococcal vaccine, polyvalent. Additional information has been requested.
Hives 24 hours after injection over left arm (deltoid), hives generalized to the all body.
Seems lethargic, sleepy, relaxed, hypotonic, not fussy, no fever, lasted 4-5 hours, post vax.
there have been no other AE reported from the patient; Caller states she administered expired MMR II; This spontaneous report was received from a certified nurse practitioner referring to a 16-years-old patient, of unknown gender. The patient's concurrent conditions, pertinent medical history, drug reactions/allergies, and concomitant medications were not provided.  On 23-MAR-2021,  the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live recombinant Human albumin (rHA) (M-M-R II) 0.5 mL (dosage regimen and route of administration were not reported) lot # S007811, expiration date 14-MAR-2021, as prophylaxis.  The reporter also stated that the vaccine had not undergone any temperature excursions, and there have been no other adverse event (AE) from the patient.
Information has been received from a physician and the medical assistant concerning a 19 year old female with no known drug allergies who "two weeks ago" on 07-AUG-2009 was vaccinated with her first dose of GARDASIL 0.5 mL, intramuscularly, Lot# 0162Y. Concomitant therapy included ADACEL Lot# UF471AA and MENACTRA U2846AA. On 07-AUG-2009, five minutes after the patient received the vaccinations, she stood up to walk to the waiting room. The patient fell to the floor, face down. The patient had syncope and seizure like activity for 5 minutes. The ambulance was called. The patient regained consciousness and was observed in the office. The patient did not go to the hospital at that time. The patient went home accompanied by her mother and aunt. On 08-AUG-2009, the patient went to the Emergency Room and complained of headache and nausea. The patient had a CT scan with normal results. The patient had bruises of the right elbow and right hip. The patient was not admitted to the hospital. The patient had recovered. The patient had a follow-up visit with the physician on 14-AUG-2009. Syncope and seizure like activity were considered to be disabling. This is one of several reports from the same source. Additional information has been requested.
Information has been received form a consumer via e-mail, who was vaccinated with a dose of MMR II (lot# not reported), on 5 different occasions and "did not developed sufficient antibodies". However, when she received the individual rubella postpartum, she finally developed a protective level of antibodies. No further information is available.
Pt recvd vax 23MAR92 & devel arthritis & suffered from an arthritic condition that caused pt to endure pain, suffering & to become disabled; no further details were provided;
11-9-01, 2 days past, excess salivation, slurred speech, right side facial weakness, right arm weakness. 2 week duration.
Staff member reported itching to her neck and right axila 25 minutes after vaccine. She was given Benadryl 50mg IM to the left deltoid at 1331 and had resolution of symptoms in minutes.
Pain, Redness, Itching Heat, Red area 4"by5" Knot in arm
4-5 inches induration surrounding left deltoid and site of injection accompanied with reddness and inflammation.
COVID-19 LESS THAN ONE WEEK AFTER THE BOOSTER; This spontaneous report received from a consumer (wife) via a company representative concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. On an unspecified date, the patient received vaccination with covid-19 vaccine ad26.cov2.s (unspecified manufacturer) (dose number in series 1) (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported for prophylactic vaccination. No adverse events associated with covid-19 vaccine ad26.cov2.s (dose number in series 1) were reported. On an unspecified date, the patient was vaccinated with covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of admin, batch number and expiry date were not reported) dose was not reported, for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, following vaccination with covid-19 vaccine ad26.cov2.s , the patient experienced got Coronavirus-19 (COVID-19) less than a week after the booster (dose number in series 2). The case of Covid-19 was reported as mild/moderate and the patient was high risk. On 02-DEC-2021, he received an infusion of Monoclonal antibodies and felt better after the infusion. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from covid-19.  This report was non-serious. This case, from the same reporter is linked to 20211212660.
Chills, Body Ache, Nausea, Tiredness   At the injection site: bruising, soreness, bleeding
pt recv vax 17JUN97 awoke @ 4AM;18JUN97 c/o hives & SOB, itching;DPH was given & pt slept & awoke later feeling better;
9PM 31JUL95 states pt had a  high pitched cry for 1 1/2 hr; has no fever stopped crying ate & is sleeping now;
This spontaneous report was received from a medical assistant refers to unspecified patients of unknown age and gender. No relevant medical history of the patients was reported. On 19-MAY-2014, the patients were vaccinated with 2 doses of RECOMBIVAX HB (strength, route of administration, lot number and expiration dates were not reported). Thimerosal status was not provided. No concomitant medications were reported. It was reported that on an unknown date, these vaccine doses had reached a low temperature of 32.9 Fahrenheit for 9.5 hours and were supported. No adverse effects were reported. There was no product quality complaint involved. The outcome was unknown. This case is linked to Case # 1405USA011843, Case # 1405USA014111, Case # 1405USA014112 via the same reporter link. Additional information has been requested.
At 1606 in the observation room, pt verbalized "I don't feel well". Pt appeared flushed. VS taken as the following: BP 111/82 T 98.2 P 86 R18 O2 sat 97%. Pt reported she felt nauseated. She got up and used the bathroom. She was accompanied by one nurse. In the restroom she stated she was experiencing very intense abdominal cramps. She asked to call EMS. But later when they came she was feeling better and refused to go with EMS. At 1705 the client was administered 0.5 mg of Diphenhydramine IM upon request.  Pt verbalized she was feeling better than before. She was picked up by a friend at 1745.